6
Oct
2026
Corium
About Corium
Certifications
Categories
-
Country/Region:United States
-
On CPHI since:2023
-
Certificates:3
-
Employees:100 - 249
Company types
Primary activities
Products from Corium (3)
-
Product Branded Transdermal Systems
Corium maintains +50 patents in the area of transdermal drug delivery and used its Corplex(R) technology to develop the first and only once-weekly transdermal patch for the treatment of Alzheimer's Disease - Adlarity or the branded hormonal contraceptive patch - Twirla. We are presently seeking commercial ... -
Product Generic Transdermal Patches
Corium offers full development and commercial manufacture for generic prescription transdermal systems - presently manufacturing Clonidine TDS (US market). We have several other products under development for licensing or can work with partners on their selected product opportunities. -
Product Generic and Brand Oral Film Strips
Corium can develop and/or manufacture your current oral thin film product - both sublingual and buccal product experience.
Corium Resources (2)
-
Brochure Corium Innovations: Capabilities Brochure
Company overview and CDMO Transdermal and Oral Thin Film (OTF) services available - includes products for partnering (Generic and Brand) -
Brochure Transdermal Feasibility Program
Test the ability to formulate your molecule of interest into a long-acting transdermal patch product with our 8-12 week feasibility assessment.


